dapi has been researched along with Diffuse Large B-Cell Lymphoma in 2 studies
DAPI: RN given refers to parent cpd.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Herbimycin A is a general protein tyrosine kinase inhibitor active as an antiproliferative compound against different types of mammalian cells." | 1.31 | Model of inhibition of the NPM-ALK kinase activity by herbimycin A. ( Arnold, MD; Frist, AY; Pulford, K; Turturro, F, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, MJ | 1 |
| Kwon, HY | 1 |
| Lee, EO | 1 |
| Lee, HJ | 1 |
| Ahn, KS | 2 |
| Kim, MO | 1 |
| Kim, CH | 1 |
| Kim, SH | 1 |
| Turturro, F | 1 |
| Arnold, MD | 1 |
| Frist, AY | 1 |
| Pulford, K | 1 |
2 other studies available for dapi and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
DMNQ-S17 inhibits constitutive NF-kappaB activation leading to induction of apoptosis through the activation of caspase-3 in human myeloid leukemia U937 cells.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspase Inhibitors; Cytochromes c; Drug Screening Assay | 2008 |
Model of inhibition of the NPM-ALK kinase activity by herbimycin A.
Topics: Anaplastic Lymphoma Kinase; Apoptosis; Benzoquinones; Blotting, Western; Cell Cycle; Enzyme Inhibito | 2002 |